Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Velge Bertrand	2. Issuer Name and Ticker or Trading Symbol LifeMD, Inc. [ LFMD ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) C/O LIFEMD, INC., 800 THIRD AVE STE 2800	3. Date of Earliest Transaction (MM/DD/YYYY) 9/30/2019
(Street) NEW YORK, NY 10022 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								217391 ⁽¹⁾	D
Common Stock	4/15/2020		P		294118	A	$0.17	511509	D
Common Stock	8/5/2020		A		173234 ⁽⁵⁾	A	$0	684743	D
Common Stock	9/22/2020		P		96923	A	$0.65 ⁽³⁾	781666	D
Common Stock	12/3/2021		P		110000	A	$3.91 ⁽²⁾	891666	I	By Aliunde LLC

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Warrants to Purchase Common Stock	$0.28							5/15/2019	5/15/2023	Common Stock	217391		217391	D
Stock Option (Right to Buy)	$1.15	9/30/2019		A		2500 ⁽⁴⁾		9/30/2019	9/30/2024	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$1.15	12/31/2019		A		2500 ⁽⁴⁾		12/31/2019	12/31/2024	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$1.2	3/31/2020		A		2500 ⁽⁴⁾		3/31/2021	3/31/2025	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$1.5	6/30/2020		A		2500 ⁽⁴⁾		6/30/2020	6/30/2025	Common Stock	2500	$0	2500	D
Warrants to Purchase Common Stock	$4.65	9/22/2020		A		100000		9/22/2020	9/22/2024	Common Stock	100000	$0	100000	D
Stock Option (Right to Buy)	$7.95	9/30/2020		A		2500 ⁽⁴⁾		9/30/2020	9/30/2025	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$7	12/31/2020		A		2500 ⁽⁴⁾		12/31/2020	12/31/2025	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$11.98	3/31/2021		A		2500 ⁽⁴⁾		3/31/2021	3/31/2026	Common Stock	2500	$0	2500	D
Stock Option (Right to Buy)	$11.56	6/30/2020		A		2500 ⁽⁴⁾		6/30/2021	6/30/2026	Common Stock	2500	$0	2500	D

Explanation of Responses:
(1)	On October 14, 2020, the common stock of LFMD, Inc. had a reverse stock split 1-for-5, resulting in a decrease of the reporting person's ownership of 869,566 shares of common stock.
(2)	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.
(3)	Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt.
(4)	Issued as director's compensation.
(5)	Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Velge Bertrand C/O LIFEMD, INC. 800 THIRD AVE STE 2800 NEW YORK, NY 10022	X